In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 28th, 2004 | 29 | Yes |
Popular Name: BICALUTAMIDE BICALUTAMIDE
Find On: PubMed — Wikipedia — Google
CAS Numbers: 113299-38-0 , 113299-40-4 , 1185035-71-5 , 90357-06-5 , [90357-06-5]
90357-06-5; Bicalutamide (JAN/USP/INN); Casodex (TN); D00961
90357-06-5; Bicalutamide; C08160
BICALUTAMIDE; CPD000466329; SAM001246612
Propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.15 | 4.04 | -16.77 | 2 | 6 | 0 | 107 | 430.379 | 6 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 9.28e-03 g/l | DrugBank-approved |
Target | Androgen Receptor, P450 | Selleck Chemicals |
mechanism | Antiandrogen | IBScreen Bioactives |
biological_use | Antiandrogen investigated for the treatment of advanced prostate cancer | IBScreen Bioactives |
mechanism | Antiandrogen | IBScreen Bioactives |
Therapy | antineoplastic | SMDC Iconix |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP02002b | NIH Clinical Collection via PubChem |
mechanism | Prevent the action of androgens by blocking the receptors for androgens on the cells of tissues, for example, the cells of the prostate gland | IBScreen Bioactives |
Indications | prostate cancer | KeyOrganics Bioactives |
Indications | prostate cancer, hirsutism | KeyOrganics Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP02002b | NIH Clinical Collection via PubChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ANDR-4-E | Androgen Receptor (cluster #4 Of 4), Eukaryotic | Eukaryotes | 365 | 0.31 | Binding ≤ 10μM |
ANDR-4-E | Androgen Receptor (cluster #4 Of 4), Eukaryotic | Eukaryotes | 670 | 0.30 | Binding ≤ 10μM |
PRGR-2-E | Progesterone Receptor (cluster #2 Of 3), Eukaryotic | Eukaryotes | 7200 | 0.25 | Binding ≤ 10μM |
Q5EM59-1-E | Androgen Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 940 | 0.29 | Binding ≤ 10μM |
ANDR-3-E | Androgen Receptor (cluster #3 Of 3), Eukaryotic | Eukaryotes | 890 | 0.29 | Functional ≤ 10μM |
PRGR-1-E | Progesterone Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1819 | 0.28 | Functional ≤ 10μM |
Z80243-1-O | MDA-MB-453 (Breast Adenocarcinoma Cells) (cluster #1 Of 1), Other | Other | 173 | 0.33 | Functional ≤ 10μM |
Z81170-1-O | LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other | Other | 1000 | 0.29 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ANDR_MOUSE | P19091 | Androgen Receptor, Mouse | 670 | 0.30 | Binding ≤ 1μM |
ANDR_RAT | P15207 | Androgen Receptor, Rat | 365 | 0.31 | Binding ≤ 1μM |
ANDR_HUMAN | P10275 | Androgen Receptor, Human | 117 | 0.33 | Binding ≤ 1μM |
Q5EM59_BOVIN | Q5EM59 | Androgen Receptor, Bovin | 940 | 0.29 | Binding ≤ 1μM |
Q5EM59_BOVIN | Q5EM59 | Androgen Receptor, Bovin | 940 | 0.29 | Binding ≤ 10μM |
ANDR_MOUSE | P19091 | Androgen Receptor, Mouse | 670 | 0.30 | Binding ≤ 10μM |
ANDR_RAT | P15207 | Androgen Receptor, Rat | 365 | 0.31 | Binding ≤ 10μM |
ANDR_HUMAN | P10275 | Androgen Receptor, Human | 117 | 0.33 | Binding ≤ 10μM |
PRGR_RAT | Q63449 | Progesterone Receptor, Rat | 7200 | 0.25 | Binding ≤ 10μM |
PRGR_RABIT | P06186 | Progesterone Receptor, Rabit | 5600 | 0.25 | Binding ≤ 10μM |
ANDR_HUMAN | P10275 | Androgen Receptor, Human | 140 | 0.33 | Functional ≤ 10μM |
Z81170 | Z81170 | LNCaP (Prostate Carcinoma) | 1000 | 0.29 | Functional ≤ 10μM |
Z80243 | Z80243 | MDA-MB-453 (Breast Adenocarcinoma Cells) | 173 | 0.33 | Functional ≤ 10μM |
PRGR_HUMAN | P06401 | Progesterone Receptor, Human | 1819 | 0.28 | Functional ≤ 10μM |
Description | Species |
---|---|
Nuclear Receptor transcription pathway | |
Nuclear signaling by ERBB4 |